Clinical Trial Update: Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial of sirolimus for previously treated idiopathic multicentric Castleman disease has posted results, and the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castleman Disease
• Multicentric Castleman Disease

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: University of Pennsylvania | Conditions: Castleman Disease, Castleman's Disease, Multicentric | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-08-08